- Home
- MIST vs MATH Comparison
MIST vs MATH Comparison
Compare MIST & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- MATH
- Stock Information
- Founded
- MIST 2003
- MATH 2015
- Country
- MIST Canada
- MATH Hong Kong
- Employees
- MIST N/A
- MATH N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- MATH Finance/Investors Services
- Sector
- MIST Health Care
- MATH Finance
- Exchange
- MIST Nasdaq
- MATH Nasdaq
- Market Cap
- MIST 53.9M
- MATH 60.8M
- IPO Year
- MIST N/A
- MATH N/A
- Fundamental
- Price
- MIST $1.16
- MATH $2.24
- Analyst Decision
- MIST Strong Buy
- MATH
- Analyst Count
- MIST 2
- MATH 0
- Target Price
- MIST $9.50
- MATH N/A
- AVG Volume (30 Days)
- MIST 1.6M
- MATH 84.8K
- Earning Date
- MIST 05-20-2025
- MATH 01-01-0001
- Dividend Yield
- MIST N/A
- MATH N/A
- EPS Growth
- MIST N/A
- MATH N/A
- EPS
- MIST N/A
- MATH 0.17
- Revenue
- MIST N/A
- MATH $31,399,049.00
- Revenue This Year
- MIST N/A
- MATH N/A
- Revenue Next Year
- MIST N/A
- MATH N/A
- P/E Ratio
- MIST N/A
- MATH $11.51
- Revenue Growth
- MIST N/A
- MATH 291.58
- 52 Week Low
- MIST $0.63
- MATH $0.80
- 52 Week High
- MIST $2.75
- MATH $2.78
- Technical
- Relative Strength Index (RSI)
- MIST 46.48
- MATH 66.41
- Support Level
- MIST $1.28
- MATH $1.85
- Resistance Level
- MIST $1.32
- MATH $2.08
- Average True Range (ATR)
- MIST 0.12
- MATH 0.17
- MACD
- MIST 0.03
- MATH 0.05
- Stochastic Oscillator
- MIST 38.80
- MATH 95.65
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.